Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.555 USD | +2.98% | +1.64% | -9.71% |
Valuation
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 17.42 | 93.25 | 63.35 | 15.88 | 17.52 | 15.82 | - | - |
Enterprise Value (EV) 1 | 17.42 | 93.25 | 63.35 | 15.88 | 17.52 | 15.82 | 15.82 | 15.82 |
P/E ratio | -0.33 x | -8 x | -4.06 x | -0.41 x | -0.92 x | -0.68 x | -0.8 x | -0.6 x |
Yield | - | - | - | - | - | - | - | - |
Capitalization / Revenue | - | 46.3 x | - | - | - | - | - | - |
EV / Revenue | - | 46.3 x | - | - | - | - | - | - |
EV / EBITDA | - | - | - | - | - | -0.77 x | - | - |
EV / FCF | - | - | - | - | - | - | - | - |
FCF Yield | - | - | - | - | - | - | - | - |
Price to Book | - | - | - | - | - | - | - | - |
Nbr of stocks (in thousands) | 2,929 | 5,714 | 8,122 | 8,143 | 10,174 | 10,174 | - | - |
Reference price 2 | 5.946 | 16.32 | 7.800 | 1.950 | 1.722 | 1.555 | 1.555 | 1.555 |
Announcement Date | 3/27/20 | 3/17/21 | 3/23/22 | 3/29/23 | 3/28/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | - | 2.014 | - | - | - | - | - | - |
EBITDA 1 | - | - | - | - | - | -20.63 | - | - |
EBIT 1 | -8.867 | -9.586 | -14.22 | -38.83 | -18.56 | -23.65 | -23.95 | -26.3 |
Operating Margin | - | -475.97% | - | - | - | - | - | - |
Earnings before Tax (EBT) 1 | - | - | -14.18 | -38.84 | -17.98 | -23.45 | -23.95 | -26.3 |
Net income 1 | -48.17 | -9.648 | -14.18 | -38.84 | -17.98 | -23.45 | -23.95 | -26.3 |
Net margin | - | -479.05% | - | - | - | - | - | - |
EPS 2 | -18.12 | -2.040 | -1.920 | -4.770 | -1.870 | -2.295 | -1.955 | -2.580 |
Free Cash Flow | - | - | - | - | - | - | - | - |
FCF margin | - | - | - | - | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - | - | - |
Announcement Date | 3/27/20 | 3/17/21 | 3/23/22 | 3/29/23 | 3/28/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBIT 1 | -3.953 | -3.702 | -4.205 | -3.736 | -5.694 | -4.502 | -5.111 | -5.199 | -4.443 | -4.666 | -5.55 | -5.8 | -6.05 | -6.25 | - |
Operating Margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Earnings before Tax (EBT) 1 | -3.941 | -3.685 | -4.208 | -24.43 | -5.7 | -4.501 | -5.189 | -5.026 | -4.165 | -4.464 | -5.5 | -5.75 | -6 | -6.2 | - |
Net income 1 | -3.941 | -3.685 | -4.208 | -24.43 | -5.7 | -4.501 | -5.189 | -5.026 | -4.165 | -4.464 | -5.5 | -5.75 | -6 | -6.2 | - |
Net margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EPS 2 | -0.4800 | -0.4800 | -0.4800 | -3.000 | -0.7000 | -0.5400 | -0.6400 | -0.5000 | -0.4100 | -0.4400 | -0.5400 | -0.5650 | -0.5900 | -0.6050 | -0.4900 |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 11/15/21 | 3/23/22 | 5/11/22 | 8/15/22 | 11/14/22 | 3/29/23 | 5/15/23 | 8/14/23 | 11/13/23 | 3/28/24 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net Debt | - | - | - | - | - | - | - | - |
Net Cash position | - | - | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
Free Cash Flow | - | - | - | - | - | - | - | - |
ROE (net income / shareholders' equity) | - | - | - | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - | - | - | - |
Capex | - | - | - | - | - | - | - | - |
Capex / Sales | - | - | - | - | - | - | - | - |
Announcement Date | 3/27/20 | 3/17/21 | 3/23/22 | 3/29/23 | 3/28/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.71% | 15.82M | |
+19.62% | 43.34B | |
+20.44% | 21.96B | |
+10.86% | 14.09B | |
+13.07% | 13.64B | |
+37.46% | 11.43B | |
-8.59% | 6.86B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+8.46% | 5.22B |
- Stock Market
- Equities
- COCP Stock
- Financials Cocrystal Pharma, Inc.